VeriMommagnolia officinalis bark extract é seguro durante a gravidez?
No EU Annex II/III listing or harmonised CLP (H360/H361/H340/H350) was found for Magnolia officinalis bark extract; ECHA substance page lists the substance but does not show a harmonised reproductive/CMR classification. Animal/subchronic toxicity studies report effects at high oral doses but do not provide clear developmental/teratogenic evidence, and authoritative cosmetic safety bodies (CIR/SCCS) specific opinions were not found. Topical cosmetic exposure is expected to produce low but measurable systemic absorption for botanical extracts. (Sources: ECHA substance page; rat subchronic toxicity study; product/COSING listings; EWG summary).
Pregnancy-safe products containing magnolia officinalis bark extract
Related ingredients
Frequently asked questions
- magnolia officinalis bark extract é seguro durante a gravidez?
- No EU Annex II/III listing or harmonised CLP (H360/H361/H340/H350) was found for Magnolia officinalis bark extract; ECHA substance page lists the substance but does not show a harmonised reproductive/CMR classification. Animal/subchronic toxicity studies report effects at high oral doses but do not provide clear developmental/teratogenic evidence, and authoritative cosmetic safety bodies (CIR/SCCS) specific opinions were not found. Topical cosmetic exposure is expected to produce low but measurable systemic absorption for botanical extracts. (Sources: ECHA substance page; rat subchronic toxicity study; product/COSING listings; EWG summary).
- magnolia officinalis bark extract é seguro durante a amamentação?
- No harmonised reproductive/breastfeeding hazard classification or EU cosmetic ban/restriction was identified. Human data on passage into breast milk are not available; animal studies at high oral doses show organ effects but do not document lactation-specific transfer. Topical use could result in low systemic exposure; therefore risk from topical cosmetic use is expected to be low but incompletely characterised. (Sources: ECHA; PubMed toxicity reviews; WebMD/CanABaby summaries).
- magnolia officinalis bark extract é seguro para a pele do bebê?
- Hazard and mechanism scores unchanged (no evidence of reproductive/developmental or endocrine-disrupting classification). Exposure score increased by +1 for infants because topical botanical extracts can be absorbed more on immature infant skin; therefore if adult topical exposure is low-measurable (1), infant exposure is moderate (2). No infant-specific dermal toxicity or developmental studies were located. (Sources: ECHA; infant-safety summaries; topical absorption rationale).
- Como o VeriMom pontua magnolia officinalis bark extract?
- O VeriMom pontua magnolia officinalis bark extract em 93/100 (sem riscos conhecidos) com base no status EU CosIng, classificações de perigo ECHA e estudos revisados por pares no PubMed. Nosso pipeline de pontuação é totalmente transparente.
- Quais são as alternativas seguras a magnolia officinalis bark extract na gravidez?
- Veja nossa lista curada de alternativas seguras a magnolia officinalis bark extract com base em função semelhante e classificação sem riscos conhecidos.
Verifique qualquer rótulo em 2 segundos
Baixe o VeriMom grátis — escaneie qualquer produto e veja a pontuação de segurança na gravidez instantaneamente.
Aviso Médico
Estas informações são apenas para fins educacionais e não constituem aconselhamento médico. As pontuações de segurança são baseadas em dados publicamente disponíveis e podem não refletir todos os riscos. Sempre consulte seu profissional de saúde antes de usar qualquer produto durante a gravidez ou amamentação.